Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123059232 | 12305923 | 2 | F | 20111109 | 20160823 | 20160426 | 20160902 | EXP | JP-CELGENEUS-087-50794-13032490 | CELGENE | 72.85 | YR | M | Y | 60.00000 | KG | 20160902 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123059232 | 12305923 | 1 | PS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 2 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 3 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 4 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 5 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 6 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 7 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 8 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 9 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 10 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 11 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 12 | SS | VIDAZA | AZACITIDINE | 1 | Intravenous drip | U | 0 | 75 | MG/M**2 | INJECTION | QD | ||||||
| 123059232 | 12305923 | 13 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123059232 | 12305923 | 14 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123059232 | 12305923 | 15 | C | LONGES | LISINOPRIL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123059232 | 12305923 | 16 | C | VFEND | VORICONAZOLE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123059232 | 12305923 | 17 | C | PRIMOBOLAN-DEPOT | METHENOLONE ENANTHATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123059232 | 12305923 | 18 | C | ITRIZOLE | ITRACONAZOLE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123059232 | 12305923 | 19 | C | EXJADE | DEFERASIROX | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 123059232 | 12305923 | 20 | C | RENIVACE | ENALAPRIL | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123059232 | 12305923 | 1 | Myelodysplastic syndrome |
| 123059232 | 12305923 | 2 | Acute leukaemia |
| 123059232 | 12305923 | 13 | Product used for unknown indication |
| 123059232 | 12305923 | 15 | Product used for unknown indication |
| 123059232 | 12305923 | 16 | Product used for unknown indication |
| 123059232 | 12305923 | 17 | Product used for unknown indication |
| 123059232 | 12305923 | 18 | Product used for unknown indication |
| 123059232 | 12305923 | 19 | Product used for unknown indication |
| 123059232 | 12305923 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123059232 | 12305923 | OT |
| 123059232 | 12305923 | DE |
| 123059232 | 12305923 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123059232 | 12305923 | Acute leukaemia | |
| 123059232 | 12305923 | Constipation | |
| 123059232 | 12305923 | Neutrophil count decreased | |
| 123059232 | 12305923 | Pneumonia fungal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123059232 | 12305923 | 1 | 20111107 | 20111115 | 0 | |
| 123059232 | 12305923 | 2 | 20111206 | 20111214 | 0 | |
| 123059232 | 12305923 | 3 | 20120117 | 20120125 | 0 | |
| 123059232 | 12305923 | 4 | 20120221 | 20120224 | 0 | |
| 123059232 | 12305923 | 5 | 20120327 | 20120330 | 0 | |
| 123059232 | 12305923 | 6 | 20120423 | 20120429 | 0 | |
| 123059232 | 12305923 | 7 | 20120521 | 20120529 | 0 | |
| 123059232 | 12305923 | 8 | 20121125 | 20121128 | 0 | |
| 123059232 | 12305923 | 9 | 20130120 | 20130121 | 0 | |
| 123059232 | 12305923 | 10 | 20130218 | 20130219 | 0 | |
| 123059232 | 12305923 | 11 | 20130416 | 20130422 | 0 | |
| 123059232 | 12305923 | 12 | 20130519 | 20130523 | 0 | |
| 123059232 | 12305923 | 16 | 20120615 | 20120731 | 0 | |
| 123059232 | 12305923 | 17 | 20120920 | 0 | ||
| 123059232 | 12305923 | 18 | 20120822 | 0 | ||
| 123059232 | 12305923 | 19 | 20121018 | 0 | ||
| 123059232 | 12305923 | 20 | 20120617 | 0 |